Bio Green Med Solution, Inc. SEC filings BGMSP

Bio Green Med Solution, Inc. has 1,000 filings in SEC EDGAR's recent list, going back to Mar 31, 2010. Its latest annual report, Form 10-K, was filed on Mar 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (listing notice). The company's fiscal year ends on December 31.

Bio Green Med Solution, Inc. SEC filings
Form Description Filed Period
8-K Current report
Listing notice
Nov 4, 2026 Oct 29, 2026
S-3 Shelf registration Oct 23, 2026 —
8-K Current report
Other events
Oct 16, 2026 Oct 16, 2026
424B3 Prospectus Oct 9, 2026 —
EFFECT Filing Oct 8, 2026 —
S-4/A Filing Sep 11, 2026 —
S-4/A Filing Aug 21, 2026 —
10-Q Quarterly report Aug 14, 2026 Jun 30, 2026
8-K Current report
Results of operations, Regulation FD disclosure
Aug 14, 2026 Aug 12, 2026
S-4/A Filing Jul 24, 2026 —
8-K Current report
Other events
Jul 1, 2026 Jul 1, 2026
8-K Current report
Shareholder vote results
Jun 22, 2026 Jun 18, 2026
S-4 Registration for a merger or exchange Jun 16, 2026 —
8-K Current report
Material agreement, Unregistered share sale
Jun 10, 2026 Jun 10, 2026
425 Filing Jun 4, 2026 —
8-K Current report
Material agreement, Regulation FD disclosure
Jun 4, 2026 Jun 4, 2026
10-Q Quarterly report May 15, 2026 Mar 31, 2026
8-K Current report
Results of operations, Regulation FD disclosure
May 14, 2026 May 14, 2026
DEFR14A Filing May 1, 2026 —
DEF 14A Proxy statement Apr 27, 2026 Apr 27, 2026
8-K Current report
Other events
Apr 13, 2026 Apr 13, 2026
10-K Annual report Mar 30, 2026 Dec 31, 2025
8-K Current report
Results of operations, Regulation FD disclosure
Mar 30, 2026 Mar 30, 2026
8-K Current report
Listing notice
Mar 13, 2026 Mar 12, 2026
8-K Current report
Other events
Jan 12, 2026 Jan 12, 2026
S-8 Employee stock plan registration Nov 28, 2025 —
10-K/A Amended annual report Nov 26, 2025 Dec 31, 2024
10-Q Quarterly report Nov 13, 2025 Sep 30, 2025
8-K Current report
Results of operations, Regulation FD disclosure
Nov 13, 2025 Nov 13, 2025
8-K Current report
Material agreement, Unregistered share sale
Nov 6, 2025 Nov 5, 2025
8-K Current report
Other events
Oct 7, 2025 Oct 7, 2025
8-K Current report
Material agreement, Acquisition or sale of assets
Oct 7, 2025 Oct 6, 2025
8-K Current report
Officer or director change
Sep 25, 2025 Sep 19, 2025
8-K/A Amended current report
Other events
Sep 17, 2025 Sep 12, 2025
424B3 Prospectus Sep 17, 2025 —
8-K Current report
Listing notice
Sep 16, 2025 Sep 12, 2025
425 Filing Sep 12, 2025 —
8-K Current report
Acquisition or sale of assets, Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure
Sep 12, 2025 Sep 12, 2025
EFFECT Filing Sep 11, 2025 —
425 Filing Sep 5, 2025 —
8-K Current report
Shareholder vote results
Sep 5, 2025 Sep 4, 2025
8-K Current report
Material agreement, Unregistered share sale
Sep 4, 2025 Sep 4, 2025
POS AM Filing Sep 2, 2025 —
8-K Current report
Material agreement
Sep 2, 2025 Sep 1, 2025
8-K Current report
Auditor change
Aug 28, 2025 Aug 22, 2025
DEFA14A Additional proxy material Aug 25, 2025 —
425 Filing Aug 25, 2025 —
424B3 Prospectus Aug 25, 2025 —
CORRESP Letter to the SEC Aug 22, 2025 —
POS AM Filing Aug 22, 2025 —
10-Q Quarterly report Aug 14, 2025 Jun 30, 2025
425 Filing Aug 13, 2025 —
8-K Current report
Results of operations, Regulation FD disclosure
Aug 13, 2025 Aug 13, 2025
8-K Current report Aug 13, 2025 Aug 12, 2025
424B3 Prospectus Aug 5, 2025 —
EFFECT Filing Aug 4, 2025 —
CORRESP Letter to the SEC Jul 31, 2025 —
UPLOAD Letter from the SEC Jul 31, 2025 —
S-1/A Amended registration statement Jul 31, 2025 —
CORRESP Letter to the SEC Jul 30, 2025 —
8-K Current report
Bylaw or fiscal year change
Jul 28, 2025 Jul 28, 2025
EFFECT Filing Jul 25, 2025 —
424B3 Prospectus Jul 25, 2025 —
UPLOAD Letter from the SEC Jul 25, 2025 —
CORRESP Letter to the SEC Jul 24, 2025 —
CORRESP Letter to the SEC Jul 24, 2025 —
S-4 Registration for a merger or exchange Jul 24, 2025 —
POS AM Filing Jul 24, 2025 —
S-1 Registration statement Jul 24, 2025 —
S-8 POS Filing Jul 24, 2025 —
425 Filing Jul 16, 2025 —
8-K Current report
Regulation FD disclosure
Jul 16, 2025 Jul 15, 2025
DEF 14C Information statement Jul 7, 2025 Jul 7, 2025
UPLOAD Letter from the SEC Jul 7, 2025 —
425 Filing Jul 7, 2025 —
8-K Current report
Material agreement, Regulation FD disclosure
Jul 7, 2025 Jul 7, 2025
8-K Current report
Bylaw or fiscal year change, Regulation FD disclosure
Jul 2, 2025 Jul 2, 2025
8-K Current report
Shareholder vote results
Jun 30, 2025 Jun 30, 2025
DRS Filing Jun 27, 2025 —
DEFA14A Additional proxy material Jun 25, 2025 —
PRE 14C Filing Jun 25, 2025 Jun 25, 2025
8-K Current report
Material agreement, Unregistered share sale, Change to shareholder rights, Bylaw or fiscal year change, Other events
Jun 20, 2025 Jun 20, 2025
UPLOAD Letter from the SEC Jun 20, 2025 —
DRS Filing Jun 16, 2025 —
8-K Current report
Other events
Jun 3, 2025 Jun 3, 2025
8-K Current report
Other events
Jun 3, 2025 Jun 3, 2025
DEF 14C Information statement May 23, 2025 May 23, 2025
8-K Current report
Results of operations
May 15, 2025 May 14, 2025
10-Q Quarterly report May 14, 2025 Mar 31, 2025
PRE 14C Filing May 13, 2025 May 13, 2025
8-K Current report
Bylaw or fiscal year change, Regulation FD disclosure
May 7, 2025 May 7, 2025
8-K Current report
Material agreement, Regulation FD disclosure
May 6, 2025 May 6, 2025
424B3 Prospectus May 1, 2025 —
EFFECT Filing Apr 29, 2025 —
CORRESP Letter to the SEC Apr 28, 2025 —
8-K Current report
Bylaw or fiscal year change
Apr 25, 2025 Apr 25, 2025
S-1 Registration statement Apr 25, 2025 —
DEF 14A Proxy statement Apr 24, 2025 Apr 24, 2025
8-K Current report
Other events
Apr 21, 2025 Apr 21, 2025
S-8 Employee stock plan registration Apr 17, 2025 —
UPLOAD Letter from the SEC Apr 14, 2025 —
DRS Filing Apr 10, 2025 —
DEF 14C Information statement Apr 3, 2025 Apr 3, 2025
10-K Annual report Apr 2, 2025 Dec 31, 2024
8-K Current report
Results of operations, Officer or director change, Regulation FD disclosure
Apr 2, 2025 Mar 31, 2025
NT 10-K Filing Mar 31, 2025 Dec 31, 2024
D Filing Mar 25, 2025 —
8-K Current report
Material agreement, Unregistered share sale, Change to shareholder rights, Bylaw or fiscal year change, Other events
Mar 24, 2025 Mar 21, 2025
PRE 14C Filing Mar 24, 2025 Mar 24, 2025
8-K Current report
Material agreement, Acquisition or sale of assets
Mar 14, 2025 Mar 10, 2025
SC 14F1 Filing Mar 5, 2025 —
8-K Current report
Material agreement, Listing notice, Change to shareholder rights, Change in control, Officer or director change
Feb 27, 2025 Feb 26, 2025
8-K Current report
Material agreement
Feb 24, 2025 Feb 20, 2025
D Filing Feb 14, 2025 —
D Filing Feb 14, 2025 —
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change
Feb 12, 2025 Feb 6, 2025
8-K Current report
Material agreement, Unregistered share sale, Shareholder vote results, Other events
Feb 6, 2025 Feb 4, 2025
8-K Current report
Other events
Feb 5, 2025 Jan 31, 2025
DEF 14A Proxy statement Jan 21, 2025 Feb 6, 2025
PRER14A Filing Jan 10, 2025 —
8-K Current report
Material agreement
Jan 10, 2025 Jan 9, 2025
PRE 14A Preliminary proxy statement Jan 8, 2025 Jan 7, 2025
8-K Current report
Material agreement, Unregistered share sale, Change to shareholder rights, Officer or director change, Bylaw or fiscal year change, Other events
Jan 6, 2025 Jan 2, 2025
8-K Current report
Listing notice
Dec 12, 2024 Dec 6, 2024
D Filing Nov 26, 2024 —
8-K Current report
Material agreement, Unregistered share sale, Change to shareholder rights, Other events
Nov 15, 2024 Nov 13, 2024
10-Q Quarterly report Nov 12, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 12, 2024 Nov 12, 2024
8-K Current report
Auditor change
Nov 12, 2024 Nov 5, 2024
RW Filing Nov 7, 2024 —
8-K Current report
Listing notice
Oct 24, 2024 Oct 22, 2024
S-1 Registration statement Oct 9, 2024 —
8-K Current report
Other events
Sep 6, 2024 Sep 4, 2024
8-K Current report
Listing notice
Aug 30, 2024 Aug 29, 2024
8-K Current report
Listing notice
Aug 26, 2024 Aug 22, 2024
8-K Current report
Auditor change
Aug 22, 2024 Aug 19, 2024
10-Q Quarterly report Aug 14, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 14, 2024 Aug 14, 2024
S-8 Employee stock plan registration Jul 31, 2024 —
8-K Current report
Officer or director change, Shareholder vote results, Other events
Jun 25, 2024 Jun 21, 2024
D Filing May 17, 2024 —
10-Q Quarterly report May 14, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 14, 2024 May 14, 2024
EFFECT Filing May 13, 2024 —
424B3 Prospectus May 13, 2024 —
CORRESP Letter to the SEC May 10, 2024 —
UPLOAD Letter from the SEC May 10, 2024 —
ARS Annual report to shareholders May 8, 2024 Dec 31, 2023
DEFA14A Additional proxy material May 8, 2024 —
DEF 14A Proxy statement May 8, 2024 Jun 21, 2024
S-1 Registration statement May 6, 2024 —
8-K Current report
Material agreement, Unregistered share sale, Other events
May 2, 2024 Apr 30, 2024
RW Filing Apr 29, 2024 —
10-K/A Amended annual report Apr 29, 2024 Dec 31, 2023
8-K Current report
Other events
Apr 26, 2024 Apr 26, 2024
S-1/A Amended registration statement Apr 25, 2024 —
S-1/A Amended registration statement Apr 19, 2024 —
8-K Current report
Listing notice
Mar 28, 2024 Mar 27, 2024
S-1 Registration statement Mar 22, 2024 —
10-K Annual report Mar 21, 2024 Dec 31, 2023
8-K Current report
Results of operations
Mar 19, 2024 Mar 19, 2024
424B3 Prospectus Feb 14, 2024 —
EFFECT Filing Feb 13, 2024 —
CORRESP Letter to the SEC Feb 12, 2024 —
S-1/A Amended registration statement Feb 8, 2024 —
CORRESP Letter to the SEC Feb 7, 2024 —
8-K Current report
Officer or director change, Other events
Jan 30, 2024 Jan 25, 2024
UPLOAD Letter from the SEC Jan 26, 2024 —
S-1 Registration statement Jan 19, 2024 —
8-K Current report
Other events
Jan 12, 2024 Jan 12, 2024
8-K Current report
Regulation FD disclosure
Jan 9, 2024 Jan 8, 2024
8-K Current report
Other events
Jan 4, 2024 Jan 4, 2024
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
Dec 26, 2023 Dec 21, 2023
424B5 Prospectus supplement Dec 26, 2023 —
8-K Current report
Shareholder vote results
Dec 12, 2023 Dec 8, 2023
10-Q Quarterly report Nov 29, 2023 Sep 30, 2023
10-K/A Amended annual report Nov 29, 2023 Dec 31, 2022
8-K Current report
Listing notice
Nov 28, 2023 Nov 21, 2023
NT 10-Q Filing Nov 15, 2023 Sep 30, 2023
8-K Current report
Restatement
Nov 15, 2023 Nov 14, 2023
DEF 14A Proxy statement Nov 14, 2023 Dec 8, 2023
8-K Current report
Results of operations
Nov 13, 2023 Nov 13, 2023
8-K Current report
Bylaw or fiscal year change
Nov 7, 2023 Nov 2, 2023
PRE 14A Preliminary proxy statement Nov 2, 2023 Dec 14, 2023
EFFECT Filing Sep 13, 2023 —
CORRESP Letter to the SEC Sep 11, 2023 —
8-K Current report
Other events
Sep 8, 2023 Sep 6, 2023
UPLOAD Letter from the SEC Sep 7, 2023 —
S-3 Shelf registration Sep 1, 2023 —
10-Q Quarterly report Aug 10, 2023 Jun 30, 2023
8-K Current report
Results of operations
Aug 9, 2023 Aug 9, 2023
S-8 Employee stock plan registration Jul 24, 2023 —
8-K Current report
Listing notice
Jul 7, 2023 Jul 5, 2023
8-K Current report
Officer or director change, Shareholder vote results, Other events
Jun 14, 2023 Jun 13, 2023
10-Q Quarterly report May 11, 2023 Mar 31, 2023
8-K Current report
Results of operations
May 11, 2023 May 11, 2023
8-K Current report
Officer or director change
May 4, 2023 Apr 28, 2023
ARS Annual report to shareholders Apr 28, 2023 Dec 31, 2022
DEFA14A Additional proxy material Apr 28, 2023 —
DEF 14A Proxy statement Apr 28, 2023 Jun 13, 2023

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Wholesale-Durable Goods, NEC (SIC 5099)
Listed as
BGMS (Nasdaq), BGMSP (OTC)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Berkeley Heights, NJ
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1130166
Former names
Cyclacel Pharmaceuticals, Inc. (until Sep 12, 2025); XCYTE THERAPIES INC (until Mar 24, 2006)

Other Wholesale-Durable Goods, NEC companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.